查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404823

骶髂關節融合術市場規模、佔有率和趨勢分析報告：2024-2030 年按適應症、治療類型、最終用戶、地區和細分市場進行的預測

Sacroiliac Joint Fusion Market Size, Share & Trends Analysis Report By Indication (Degenerative Sacroiliitis, Sacral Disruption), By Treatment Type (Surgery, Injections), By End-user, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 162 Pages | 商品交期: 2-10個工作天內

價格

骶髂關節融合術市場的成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球骶髂關節融合術市場規模預計將達到 24.9 億美元。

預計 2024 年至 2030 年複合年成長率為 19.8%。開拓的市場參與者大力投資研發 (R&D) 活動，以開發創新且有效的設備。研發活動的增加預計將推動未來幾年的市場成長。此外，由於骨骼病患病率的增加和技術的進步，預計市場將進一步成長。

腰痛、臀部疼痛、鼠蹊部疼痛和下肢疼痛的盛行率不斷上升將推動 SI融合術市場的成長。這些慢性且使人衰弱的型態已經變得非常普遍，影響著世界上很大一部分人口。這一趨勢為醫療保健系統帶來了重大挑戰，並刺激了對緩解疼痛和恢復活動能力的創新解決方案的需求。正如醫療保險和醫療補助服務中心 2021 年 12 月報告的那樣，下背部、臀部、鼠蹊部和下肢的慢性疼痛佔骶髂關節疾病病例的大多數，佔病例的 10% 至 26%。與骶髂關節疾病相關的症狀的普遍存在凸顯了醫療保健面臨的重大挑戰。

此外，推動市場開拓的因素包括擴大使用創新材料和技術來開發改進且更安全的骶髂關節固定系統。例如，2022年10月，專注於微創方法的再生技術公司Aurora Spine宣布取得專利的SiLO TFX MIS獲得美國FDA 510(k)許可。此骶髂關節固定系統是針對骶髂關節破壞或退化性骶髂關節炎病例進行骶髂關節固定的微創解決方案。 SiLO TFX 系統由髂骨螺釘、骶骨螺釘、相關器械和定序錐體組成，旨在實現骶骨和髂骨之間骨融合的固定和穩定性。因此，此類技術進步預計將推動市場成長。

2023年，北美以最大的收益佔有率主導市場。北美引領全球上肢義肢市場。這一優勢得益於先進的醫療基礎設施、主要企業的存在以及擴大的報銷範圍。主要企業正在實施舉措，例如產品臨床試驗、地理擴張、專利申請、產品發布以及聯盟和合作，以擴大市場佔有率。

骶髂關節融合術市場報告亮點

  • 有跡象表明，退化性骶髂關節炎細分市場在 2023 年佔據最大收益佔有率，達到 38.6%。人們對該疾病的認知不斷提高，骶髂關節疾病的診斷能力不斷提高，是推動這一領域成長的主要因素。
  • 按治療類型分類，2023 年手術細分市場的收益佔有率佔據市場主導地位。其優越性是由於微創手術因其切口更小、疼痛和疤痕減少以及恢復時間更快等優點而受到越來越多的偏好。
  • 按最終用途分類，醫院細分市場將在 2023 年佔據主導地位。醫院為患者提供專業的長期護理，並且他們的治療通常需要報銷，這進一步推動了它們的採用。
  • 由於醫療保健基礎設施的建立和公司研發投資的增加，北美在 2023 年佔據了最大的收益佔有率。
  • 由於龐大的患者群、醫療保健設施的發展以及主要企業的投資，預計亞太地區在預測期內將以最快的速度成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章骶髂關節融合市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 骶髂關節融合市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章骶髂關節融合術市場：指標估計與趨勢分析

  • 定義和範圍
    • 退化性骶髂關節炎
    • 骶骨破壞
    • 創傷
  • 2023年及2030年指示市場佔有率
  • 細分儀表板
  • 按適應症分類的全球骶髂關節融合術市場前景
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 退化性骶髂關節炎
    • 骶骨破壞
    • 創傷

第5章骶髂關節融合術市場：治療類型估計與趨勢分析

  • 定義和範圍
    • 外科手術
    • 注射
    • 射頻消融術
  • 治療類型市場佔有率，2023 年和 2030 年
  • 細分儀表板
  • 按治療類型分類的全球骶髂關節融合術市場前景
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 外科手術
    • 注射
    • 射頻消融術

第6章骶髂關節融合市場：最終用戶估計和趨勢分析

  • 定義和範圍
    • 醫院
    • 門診手術中心
    • 其他
  • 2023年及2030年最終用戶市場佔有率
  • 細分儀表板
  • 按最終用戶前景分類的全球骶髂關節融合市場
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 醫院
    • 門診手術中心
    • 其他

第7章骶髂關節融合市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • 創新者
  • 供應商形勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • SI-BONE, Inc.
    • PainTEQ
    • CornerLoc
    • SIGNUS Medizintechnik GmbH
    • Globus Medical
    • Orthofix Medical, Inc.
    • Life Spine, Inc.
    • Camber Spine Technologies, LLC
    • CoreLink Surgical
    • Xtant Medical
    • Surgalign Spine Technologies, Inc.
    • Medtronic
Product Code: GVR-4-68039-805-9

Sacroiliac Joint Fusion Market Growth & Trends:

The global sacroiliac joint fusion market size is expected to reach USD 2.49 billion by 2030, according to a new report by Grand View Research, Inc.It is expected to expand at a CAGR of 19.8% from 2024 to 2030. Key market players are investing substantially in Research & Development (R&D) activities to create innovative and effective devices. This increase in R&D activities is expected to drive market growth over the coming years. In addition, the market is expected to grow further due to the increasing prevalence of bone disorders and ongoing technological advancements.

Increasing prevalence of lower back, buttock, groin, and lower extremity pain drives SI joint fusion market growth. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels demand for innovative solutions to alleviate suffering and restore mobility. Chronic pain in the lower back, buttock, groin, and lower extremity represents a significant portion of SI joint disorder cases, comprising 10% to 26% of such cases, as the Centers for Medicare & Medicaid Services reported in December 2021. The prevalence of symptoms associated with SI joint disorders highlights their substantial healthcare challenge.

In addition, a factor propelling market growth is the increasing use of innovative materials and technologies to develop improved and safer SI joint fusion systems. For instance, in October 2022, Aurora Spine, a company specializing in regenerative technologies focusing on minimally invasive approaches, announced that it had received 510(k) clearance from the U.S. FDA for its patented SiLO TFX MIS. The SI joint fixation system is a minimally invasive solution intended for SI joint fusion in cases involving SI joint disruptions and degenerative sacroiliitis. The SiLO TFX system comprises an ilium screw, sacrum screw, associated instrumentation, and transfixing cone designed to achieve fixation and stability for bony fusion between the sacrum and ilium. Thus, such technological advancements are expected to boost market growth.

North America dominated the market with the largest revenue share in 2023. North America is the leading market for upper limb prosthetics across the globe. The dominance can be attributed to advanced healthcare infrastructure, the presence of key companies, and growing reimbursement coverage. Key market players are involved in implementing strategic initiatives, such as conducting clinical tests of their products, regional expansion, patent applications, product launches, and partnerships & collaborations to increase their market share.

Sacroiliac Joint Fusion Market Report Highlights:

  • By indication, the degenerative sacroiliitis segment accounted for the largest revenue share of 38.6% in 2023. Growing awareness about the condition and improving diagnostic capabilities for sacroiliac joint disorders are among the major factors that drive the growth of the segment.
  • By treatment type, surgery segment dominated the market in terms of revenue share in 2023. Its dominance is attributed to the growing preference for minimally invasive surgeries, driven by their advantages, including smaller incisions, decreased pain & scarring, and quicker recovery periods.
  • By end user, the hospitals segment dominated the market in 2023. Hospitals offer specialized, extended care for patients, and their treatments are frequently eligible for reimbursement, further fostering their adoption.
  • North America dominated the market with the largest revenue share in 2023 owing to well-established healthcare infrastructure and increasing R&D investments by companies.
  • Asia Pacific region is expected to grow at the fastest rate during the forecast period, owing to the presence of a large patient pool, developing healthcare facilities, and investments by key companies in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Treatment
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Sacroiliac Joint Fusion Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of lower back, buttock, groin, and lower extremity pain
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing cases of Sacroiliitis or Sacroiliac joint dysfunction
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness
  • 3.3. Sacroiliac Joint Fusion Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Sacroiliac Joint Fusion Market: Indication Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Degenerative sacroiliitis
    • 4.1.2. Sacral disruption
    • 4.1.3. Trauma
  • 4.2. Indication Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Sacroiliac Joint Fusion Market by Indication Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Degenerative sacroiliitis
      • 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Sacral disruption
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Trauma
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Sacroiliac Joint Fusion Market: Treatment Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Surgery
    • 5.1.2. Injections
    • 5.1.3. RF ablation
  • 5.2. Treatment Type Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Sacroiliac Joint Fusion Market by Treatment Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Surgery
      • 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Injections
      • 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. RF ablation
      • 5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Sacroiliac Joint Fusion Market: End User Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Ambulatory Surgical Centers
    • 6.1.3. Others
  • 6.2. End user Market Share, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Sacroiliac Joint Fusion Market by End User Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Hospitals
      • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 6.5.2. Ambulatory surgical centers
      • 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Others
      • 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Sacroiliac Joint Fusion Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. SI-BONE, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. PainTEQ
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. CornerLoc
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. SIGNUS Medizintechnik GmbH
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Globus Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Orthofix Medical, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Life Spine, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Camber Spine Technologies, LLC
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. CoreLink Surgical
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Xtant Medical
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Surgalign Spine Technologies, Inc.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Medtronic
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives

List of Tables

  • 1. List of Abbreviation
  • 2. North America sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 3. North America sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 4. North America sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 5. North America sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 6. U.S. sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 7. U.S. sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 8. U.S. sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 9. Canada sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 10. Canada sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 11. Canada sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 12. Europe sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 13. Europe sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 14. Europe sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 15. Europe sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 16. Germany sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 17. Germany sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 18. Germany sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 19. UK sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 20. UK sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 21. UK sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 22. France sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 23. France sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 24. France sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 25. Italy sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 26. Italy sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 27. Italy sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 28. Spain sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 29. Spain sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 30. Spain sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 31. Denmark sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 32. Denmark sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 33. Denmark sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 34. Sweden sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 35. Sweden sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 36. Sweden sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 37. Norway sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 38. Norway sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 39. Norway sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 40. Asia Pacific sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 41. Asia Pacific sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 42. Asia Pacific sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 43. Asia Pacific sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 44. China sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 45. China sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 46. China sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 47. Japan sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 48. Japan sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 49. Japan sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 50. India sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 51. India sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 52. India sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 53. South Korea sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 54. South Korea sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 55. South Korea sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 56. Australia sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 57. Australia sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 58. Australia sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 59. Thailand sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 60. Thailand sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 61. Thailand sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 62. Latin America sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 63. Latin America sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 64. Latin America surgical ablation market, by treatment type, 2018 - 2030 (USD Million)
  • 65. Latin America laparoscopic ablation market, by end user, 2018 - 2030 (USD Million)
  • 66. Brazil sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 67. Brazil sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 68. Brazil sacroiliac joint market, by end user, 2018 - 2030 (USD Million)
  • 69. Mexico sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 70. Mexico sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 71. Mexico surgical ablation market, by end user, 2018 - 2030 (USD Million)
  • 72. Argentina sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 73. Argentina sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 74. Argentina surgical ablation market, by end user, 2018 - 2030 (USD Million)
  • 75. MEA sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 76. MEA sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 77. MEA sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 78. MEA sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 79. South Africa sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 80. South Africa sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 81. South Africa sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 82. Saudi Arabia sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 83. Saudi Arabia sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 84. Saudi Arabia sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 85. UAE sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 86. UAE sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 87. UAE sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 88. Kuwait sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 89. Kuwait sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 90. Kuwait sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)  

List of Figures

  • 1. Market research process
  • 2. Data triangulation techniques
  • 3. Primary research pattern
  • 4. Primary interviews in North America
  • 5. Primary interviews in Europe
  • 6. Primary interviews in APAC
  • 7. Primary interviews in Latin America
  • 8. Primary interviews in MEA
  • 9. Market research approaches
  • 10. Value-chain-based sizing & forecasting
  • 11. QFD modeling for market share assessment
  • 12. Market formulation & validation
  • 13. Sacroiliac joint fusion market: market outlook
  • 14. Sacroiliac joint fusion competitive insights
  • 15. Parent market outlook
  • 16. Related/ancillary market outlook
  • 17. Penetration and growth prospect mapping
  • 18. Industry value chain analysis
  • 19. Sacroiliac joint fusion market driver impact
  • 20 Sacroiliac joint fusion market restraint impact
  • 21. Sacroiliac joint fusion market strategic initiatives analysis
  • 22. Sacroiliac joint fusion market: Indication movement analysis
  • 23. Sacroiliac joint fusion market: Indication outlook and key takeaways
  • 24. Degenerative sacroiliitis market estimates and forecast, 2018 - 2030
  • 25. Sacral disruption market estimates and forecast, 2018 - 2030
  • 26. Trauma market estimates and forecast, 2018 - 2030
  • 27. Sacroiliac joint fusion market: Treatment Type Movement Analysis
  • 28. Sacroiliac joint fusion market: Treatment Type outlook and key takeaways
  • 29. Surgery market estimates and forecast, 2018 - 2030
  • 30. MIS market estimates and forecast,2018 - 2030
  • 31. Open market estimates and forecast, 2018 - 2030
  • 32. Dorsal & Anterior market estimates and forecast,2018 - 2030
  • 33 Lateral market estimates and forecast, 2018 - 2030
  • 34. Implants market estimates and forecast,2018 - 2030
  • 35. Accessories market estimates and forecast,2018 - 2030
  • 36. Injections market estimates and forecast,2018 - 2030
  • 37. Diagnosis market estimates and forecast,2018 - 2030
  • 38 Treatment market estimates and forecast,2018 - 2030
  • 39. RF ablation market estimates and forecast,2018 - 2030
  • 40 Sacroiliac joint fusion market: End User Movement Analysis
  • 41 Sacroiliac joint fusion market: End User outlook and key takeaways
  • 42 Hospitals market estimates and forecast, 2018 - 2030
  • 43 Ambulatory surgical centers market estimates and forecast,2018 - 2030
  • 44 Others market estimates and forecast, 2018 - 2030
  • 45 Global Sacroiliac joint fusion market: Regional movement analysis
  • 46 Global Sacroiliac joint fusion market: Regional outlook and key takeaways
  • 47 Global Sacroiliac joint fusion market share and leading players
  • 48 North America market share and leading players
  • 49 Europe market share and leading players
  • 50 Asia Pacific market share and leading players
  • 51. Latin America market share and leading players
  • 52. Middle East & Africa market share and leading players
  • 53. North America: SWOT
  • 54. Europe SWOT
  • 55. Asia Pacific SWOT
  • 56. Latin America SWOT
  • 57. MEA SWOT
  • 58. North America, by country
  • 59. North America
  • 60. North America market estimates and forecast, 2018 - 2030
  • 61. U.S.
  • 62. U.S. market estimates and forecast, 2018 - 2030
  • 63. Canada
  • 64. Canada market estimates and forecast, 2018 - 2030
  • 65. Europe
  • 66. Europe market estimates and forecast, 2018 - 2030
  • 67. UK
  • 68. UK market estimates and forecast, 2018 - 2030
  • 69. Germany
  • 70. Germany market estimates and forecast, 2018 - 2030
  • 71.. France
  • 72. France market estimates and forecast, 2018 - 2030
  • 73. Italy
  • 74. Italy market estimates and forecast, 2018 - 2030
  • 75. Spain
  • 76. Spain market estimates and forecast, 2018 - 2030
  • 77. Denmark
  • 78. Denmark market estimates and forecast, 2018 - 2030
  • 79. Sweden
  • 80. Sweden market estimates and forecast, 2018 - 2030
  • 81. Norway
  • 82. Norway market estimates and forecast, 2018 - 2030
  • 83. Asia Pacific
  • 84. Asia Pacific market estimates and forecast, 2018 - 2030
  • 85. China
  • 86. China market estimates and forecast, 2018 - 2030
  • 87. Japan
  • 88. Japan market estimates and forecast, 2018 - 2030
  • 89. India
  • 90. India market estimates and forecast, 2018 - 2030
  • 91. Thailand
  • 92. Thailand market estimates and forecast, 2018 - 2030
  • 93. South Korea
  • 94. South Korea market estimates and forecast, 2018 - 2030
  • 95. Australia
  • 96. Australia market estimates and forecast, 2018 - 2030
  • 97. Latin America
  • 98. Latin America market estimates and forecast, 2018 - 2030
  • 99. Brazil
  • 100. Brazil market estimates and forecast, 2018 - 2030
  • 101. Mexico
  • 102. Mexico market estimates and forecast, 2018 - 2030
  • 103. Argentina
  • 104. Argentina market estimates and forecast, 2018 - 2030
  • 105. Middle East and Africa
  • 106. Middle East and Africa market estimates and forecast, 2018 - 2030
  • 107. South Africa
  • 108. South Africa market estimates and forecast, 2018 - 2030
  • 109. Saudi Arabia
  • 110. Saudi Arabia market estimates and forecast, 2018 - 2030
  • 111. UAE
  • 112. UAE market estimates and forecast, 2018 - 2030
  • 113. Kuwait
  • 114. Kuwait market estimates and forecast, 2018 - 2030
  • 115. Market share of key market players- Sacroiliac joint fusion market